Please use this identifier to cite or link to this item: http://hdl.handle.net/123456789/4992
Full metadata record
DC FieldValueLanguage
dc.contributor.authorJoshi, Mayank-
dc.contributor.authorChoudhury, Angshuman Roy-
dc.date.accessioned2023-08-21T16:05:43Z-
dc.date.available2023-08-21T16:05:43Z-
dc.date.issued2022-
dc.identifier.citationBioorganic and Medicinal Chemistry, 67(1), 116835.en_US
dc.identifier.urihttps://doi.org/10.1016/j.bmc.2022.116835-
dc.identifier.urihttp://hdl.handle.net/123456789/4992-
dc.descriptionOnly IISER Mohali authors are available in the record.en_US
dc.description.abstractA strategy of “Nature-to-new” with iterative scaffold-hopping was considered for investigation of privileged ring/functional motif-elaborated analogs of natural aurones. An organocatalyzed umpolung chemistry based method was established for molecular-diversity feasible synthesis of title class of chemotypes i.e. (Z)-2-Arylideneimidazo[1,2–a]pyridinones and (Z)-2-Arylidenebenzo[d]imidazo[2,1–b]thiazol-3-ones. Various biophysical experiments indicated their important biological properties. The analogs showed characteristic anticancer activities with efficiency more than an anticancer drug. The compounds induced apoptosis with arrest in the S phase of the cell cycle regulation. The compounds’ significant effect in up/down-regulation of various apoptotic proteins, an apoptosis cascade, and the inhibition of topoisomerases-mediated DNA relaxation process was identified. The analysis of the structure-activity relationship, interference with biological events and the drug-likeness physicochemical properties of the compounds in the acceptable window indicated distinctive medicinal molecule-to-properties of the investigated chemotypes.en_US
dc.language.isoen_USen_US
dc.publisherElsevieren_US
dc.subjectOrganocatalyzed umpolungen_US
dc.subjectsynthesis of heterocyclic-fuseden_US
dc.subjectarylidene-imidazolones as anticancer agentsen_US
dc.titleOrganocatalyzed umpolung addition for synthesis of heterocyclic-fused arylidene-imidazolones as anticancer agentsen_US
dc.typeArticleen_US
Appears in Collections:Research Articles

Files in This Item:
File Description SizeFormat 
Need To Add…Full Text_PDF.15.36 kBUnknownView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.